The prevalence of anaemia in patients with cancer is reported to be approximately 40% [16] due to nutritional deficiency, chronic disease, blunted response to erythropoietin, bone marrow suppression either due to cancerous cells or as a side effect of chemotherapy/radiotherapy, and other causes [17]. The gene discussed is EPO; the disease is anemia (phenotype).